/Zoetis%20Inc%20HQ%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of $52.7 billion, Zoetis Inc. (ZTS) is a global leader in animal health, specializing in medicines, vaccines, diagnostics, and precision health solutions for both livestock and companion animals. The company serves veterinarians, livestock producers, and pet owners worldwide, with a diversified portfolio spanning vaccines, parasiticides, dermatology, anti-infectives, and advanced diagnostic services.
Shares of the Parsippany, New Jersey-based company have underperformed the broader market over the past 52 weeks. ZTS stock has decreased nearly 32% over this time frame, while the broader S&P 500 Index ($SPX) has gained 19.6%. Moreover, shares of Zoetis stock have dropped 27.3% on a YTD basis, compared to SPX's 8.7% rise.